1996
DOI: 10.1097/00005537-199603000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Arginine Vasopressin Levels in Squamous Cell Cancer of the Head and Neck

Abstract: The reported effectiveness of single tumor markers (TMs) associated with squamous cell cancer of the head and neck ranges from 15% to 71%, with most studies reporting sensitivity no higher than 50%. An increased incidence of the syndrome of inappropriate secretion of antidiuretic hormone or arginine vasopressin (SIADH) in patients with head and neck cancer has been reported. Serum arginine vasopressin (AVP) was studied as a possible TM in these patients. Sixty-three patients with squamous cell carcinoma of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
1

Year Published

2000
2000
2020
2020

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 33 publications
1
16
1
Order By: Relevance
“…The incidence of SIADH in patients presenting with head and neck cancer before the operation was 1.15%, lower than formerly reported. 1,4,5 Although ectopic production of AVP was reported in a case of nasopharyngeal carcinoma, 9 SIADH was found before surgery in only one of our cases and this does not support the assumption that the hormone is ectopically released from the tumor cells.…”
Section: Discussioncontrasting
confidence: 74%
“…The incidence of SIADH in patients presenting with head and neck cancer before the operation was 1.15%, lower than formerly reported. 1,4,5 Although ectopic production of AVP was reported in a case of nasopharyngeal carcinoma, 9 SIADH was found before surgery in only one of our cases and this does not support the assumption that the hormone is ectopically released from the tumor cells.…”
Section: Discussioncontrasting
confidence: 74%
“…These findings led him to suggest that squamous cell carcinoma produced neuropeptide Y, which stimulated production of endogenous AVP, while small cell carcinoma produced ectopic AVP directly. In addition, there has been more compelling evidence to support Lee's theory, such as the finding of increased AVP levels in 38% of SIADH patients with squamous cell carcinoma, despite no evidence of ectopic AVP (12). In the event that neuropeptide Y is detected in SIADH patients with squamous cell carcinoma, this hypothesis can be proven clinically.…”
Section: Discussionmentioning
confidence: 99%
“…However, this is a property now known to be shared by many types of tumour. Vasopressin has been shown to be produced also by prostatic and testicular tumours, ovarian cancer, pancreatic cancer (North et al 1983h;Maurer et al 1983;Friedmann et al 1993), pituitary adenomas (Kimura et al 1986) (Kavanagh et al 1992), cancer of the head and neck (Talmi et al 1996;Ferlito et al 1997), phaeochromocytoma (Grazzini, 1999) and tumourh of gastrointestinal origin (A. S. Friedmann & W. G. North, unpublished data). However, only a small percentage of squamous-cell carcinomas, adenocarcinomas, and large-cell carcinomas of the lung seem to produce vasopressin (Maurer et al 1983;North et al 198%;Friedman et al 1993).…”
Section: What Types Of Cancer Express the Vasopressin Gene?mentioning
confidence: 99%
“…SIADH refers to a condition of hyponatraemia and comparatively high urine osmolality, consistent with excessive retention of water by individuals with tumours producing vasopressin. The condition was originally associated with small-cell lung cancer, but has now been reported for breast cancer, ovarian cancer, prostatic cancer, and head and neck cancer (Kimura et al 1986;Osterman et al 1986;Hellstrom et al 1990;Kavanagh et al 1992;Talmi et al 1996;Ferlito et al 1997;A. S. Friedmann & W. G. North, unpublished data).…”
Section: What Are the Clinical Signs Of Vasopressin Gene Expression Bmentioning
confidence: 99%